搜尋結果
US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
Reuters· 3 日前... be sold under the brand name Xolremdi, is the first therapy to get U.S. approval< ... ...
Warren Buffett’s Real Estate Company Will Pay $250 Million In Antitrust Settlement
Forbes· 7 日前HomeServices of America, Warren Buffett’s real estate brokerage, reached a $250 million ...
A Tough Time To Ban Non-Competes
Forbes· 4 日前Trust in leaders is ebbing; job loyalty is tanking; service businesses are getting tougher; so ...
Council Post: 12 Negative Impacts Of Inaccurate Credit Reports
Forbes· 7 日前Just like a personal credit report, the accuracy of your business's credit report is ...
Current Climate: A $46 Million Renewable Energy Swindle
Forbes· 4 日前Consider green hydrogen, a burgeoning industry with lots of new players and big dreams of ...
A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And ...
Forbes· 7 日前American workers are increasingly experiencing a deadly combination of chronic pain and opioid ...
Japan reminds on FX readiness as data suggests $35 bln yen intervention
Reuters· 2 日前Japan stands ready to deal with foreign exchange matters around the clock, top currency ...
Revvity beats quarterly estimates on demand for diagnostic equipment
Reuters· 3 日前Contract drug manufacturers and equipment makers witnessed their biotech clients cut back on spending in 2023 amid rising ...
Binance co-founder Zhao set to keep on growing his $33 billion fortune even as he heads to ...
CNBC· 2 日前Cryptocurrency exchange Binance founder and CEO Changpeng Zhao speaks at a Binance fifth ...
neuroClues wants to put high-speed eye-tracking tech in the doctor's office
TechCrunch· 2 日前The eyes aren’t just a window into the soul; tracking saccades can help doctors pick up a range ...